Systemic toxicity to betamethasone ointment

Topically applied betamethasone for actinic keratosis may trigger systemic side effects. Systemic side effects of topical betamethasone may completely resolve after discontinuation of the causative agent. A 59‐year‐old male patient with scalp actinic keratosis developed fatigue and the need to sleep...

Descripción completa

Detalles Bibliográficos
Autores principales: Aliyev, Rahim, Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495834/
https://www.ncbi.nlm.nih.gov/pubmed/32983466
http://dx.doi.org/10.1002/ccr3.2957
_version_ 1783582970179747840
author Aliyev, Rahim
Finsterer, Josef
author_facet Aliyev, Rahim
Finsterer, Josef
author_sort Aliyev, Rahim
collection PubMed
description Topically applied betamethasone for actinic keratosis may trigger systemic side effects. Systemic side effects of topical betamethasone may completely resolve after discontinuation of the causative agent. A 59‐year‐old male patient with scalp actinic keratosis developed fatigue and the need to sleep shortly after starting topical betamethasone/diclofenac ointment. Additionally, he experienced vertigo, nausea, sleep disturbance, change in character and recognition, tiredness, visual impairment, and elevated blood pressure. Since all symptoms resolved completely within 48 hours after discontinuation of the ointment, they were attributed to glucocorticoids.
format Online
Article
Text
id pubmed-7495834
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74958342020-09-25 Systemic toxicity to betamethasone ointment Aliyev, Rahim Finsterer, Josef Clin Case Rep Case Reports Topically applied betamethasone for actinic keratosis may trigger systemic side effects. Systemic side effects of topical betamethasone may completely resolve after discontinuation of the causative agent. A 59‐year‐old male patient with scalp actinic keratosis developed fatigue and the need to sleep shortly after starting topical betamethasone/diclofenac ointment. Additionally, he experienced vertigo, nausea, sleep disturbance, change in character and recognition, tiredness, visual impairment, and elevated blood pressure. Since all symptoms resolved completely within 48 hours after discontinuation of the ointment, they were attributed to glucocorticoids. John Wiley and Sons Inc. 2020-05-25 /pmc/articles/PMC7495834/ /pubmed/32983466 http://dx.doi.org/10.1002/ccr3.2957 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Aliyev, Rahim
Finsterer, Josef
Systemic toxicity to betamethasone ointment
title Systemic toxicity to betamethasone ointment
title_full Systemic toxicity to betamethasone ointment
title_fullStr Systemic toxicity to betamethasone ointment
title_full_unstemmed Systemic toxicity to betamethasone ointment
title_short Systemic toxicity to betamethasone ointment
title_sort systemic toxicity to betamethasone ointment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495834/
https://www.ncbi.nlm.nih.gov/pubmed/32983466
http://dx.doi.org/10.1002/ccr3.2957
work_keys_str_mv AT aliyevrahim systemictoxicitytobetamethasoneointment
AT finstererjosef systemictoxicitytobetamethasoneointment

Ejemplares similares